Announcements Trials
Browse Landscape

Phase

Phase 2 7

Status

Terminated 7Completed 7Withdrawn 1Suspended 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

CNS 7Sarcoma 1Lymphoid 1

Conditions

Glioblastoma 5Astrocytoma 5Neuroectodermal Tumors, Primitive 2Neurocytoma 2Brain Neoplasms 2Oligodendroglioma 1Gliosarcoma 1Glioma 1Ganglioglioma 1Craniopharyngioma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × antineoplaston AS 2-1 × CNS × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003456 2018-03-22

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Glioblastoma

NCT00003474 2018-03-22

Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Glioblastoma

NCT00003470 2017-08-24

AA

Burzynski Research Institute

Phase 2 Completed
27 enrolled 6 charts
CNS

Astrocytoma

NCT00003475 2017-08-24

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Astrocytoma, Glioblastoma

NCT00003537 2017-08-24

AA

Burzynski Research Institute

Phase 2 Completed
19 enrolled 6 charts
CNS

Astrocytoma, Brain Neoplasms

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡